NP-50301

NP-50301 Uses, Dosage, Side Effects, Food Interaction and all others data.

NP-50301 is an ophthalmic therapeutic eye drop treating post-menopausal Dry Eye Syndrome (DES). It is being developed by Nascent Pharmaceuticals. It is estimated that about 30% of postmenopausal women suffer symptoms of DES, which accounts for over 12 million women in the U.S. The majority of sufferers of DES are postmenopausal women; and clinical research around the world has suggested the benefits of both topical and systemic estrogen therapy in the treatment of DES in this population.

Trial results indicate that NP50301 therapy provides a benefit in relieving the signs and symptoms presented by DES in postmenopausal women. Importantly, there were no drug-related serious adverse events in the study.

Trade Name NP-50301
Generic NP-50301
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
NP-50301
NP-50301

Uses

Investigated for use/treatment in eye disorders/infections.

How NP-50301 works

NP50301 is an estrogen ester compound believed to act by multiple mechanisms, including influencing the health of the cornea, the meibomian glands and the conjunctiva.

Innovators Monograph

You find simplified version here NP-50301

*** Taking medicines without doctor's advice can cause long-term problems.
Share